HDL cholesterol and risk of diabetic nephropathy in patient with type 1 diabetes: A meta-analysis of cohort studies

Ying Chen; Yunqing Zhi; Chengqian Li; Ying Liu; Lifang Zhang; Yangang Wang; Kui Che

doi:10.1016/j.diabres.2016.10.013

HDL cholesterol and risk of diabetic nephropathy in patient with type 1 diabetes: A meta-analysis of cohort studies

Diabetes Res Clin Pract. 2016 Dec:122:84-91. doi: 10.1016/j.diabres.2016.10.013. Epub 2016 Oct 20.

Authors

Ying Chen¹, Yunqing Zhi², Chengqian Li¹, Ying Liu³, Lifang Zhang¹, Yangang Wang¹, Kui Che⁴

Affiliations

¹ Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
² Gynaecology and Obstertrics, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, 201311, China.
³ Department of Infectious Diseases, The Affiliated Hospital of Qingdao University, Qingdao 266003, China. Electronic address: [email protected].
⁴ Laboratory of Thyroid Disease, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Electronic address: [email protected].

PMID: 27816683
DOI: 10.1016/j.diabres.2016.10.013

Abstract

A meta-analysis was conducted to assess the impact of HDL on risk of diabetic nephropathy in T1DM patients. Ten papers containing (7698) participants were included in this meta-analysis. Our meta-analysis suggest that the risk of diabetic nephropathy was decreased with HDL in type 1 diabetes.

Keywords: Diabetic nephropathy; HDL cholesterol; Meta-analysis; T1DM.

Publication types

Meta-Analysis
Review

MeSH terms

Biomarkers / blood
Cholesterol, HDL / blood*
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / complications*
Diabetic Nephropathies* / blood
Diabetic Nephropathies* / epidemiology
Diabetic Nephropathies* / etiology
Disease Progression
Global Health
Humans
Incidence
Risk Factors

Substances

Biomarkers
Cholesterol, HDL